After a tepid response to its IPO, the Gland Pharma Ltd’s stock got a lift post listing. Learn about Gland Pharma Competition, get detailed comparison of Gland Pharma with major competitors in terms of market cap, sales, net profit and assets. Actual numbers and more financial data, updated until 31 March, 2019* are included in purchased financial report. All content is posted anonymously by employees working at Gland Pharma Limited. Origin Country/Region. Biocon has acquired the companies: Nobex Corporation. Singapore. Biocon's main competitors are: Wockhardt, Aurobindo Pharma, Laurus Labs, Gland Pharma. Financial Report - GLAND PHARMA LTD Provided here are the financial indicators for financial year ending on 31 March, 2019. Gland Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation . Pet Gland Pharma Limited ("Company"). Gland Pharma - Shareholding for the Period Ended November 17, 2020 25th-Nov-2020 12:53 Source: BSE Gland Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - … Some sectors are still reeling under covid-19 pain like retail . Shares of India's Gland Pharma surged as much as 23% in their stock market debut on Friday, a flying start for the company in a market that has seen strong appetite for shares of drugmakers. Besides, the Cabinet gave its nod for another proposal where KKR would acquire 24.9 per cent stake in Gland Celsus Bio Chemicals Pvt Ltd. Peptides Market Report 2020 Comprehensive Analysis, Future Forecast by Top Competitors – Cipla Ltd., Emcure Pharmaceuticals Pvt. Gland Pharma and KKR Announce Partnership KKR & Co. L.P. Marks the largest private equity investment in an Indian pharmaceutical company MUMBAI, India-- Gland Pharma … KKR, in November last year, had announced it would acquire minority stake for $200 million in Gland Pharma. GCR (Global Competition Review) is the world's leading antitrust and competition law journal and news service. Gland Pharma Ltd. 21, 300 VIALS OF VORICONAZOLE POWDER FOR INJECTION 200MG/VIAL, 30ML VIAL 1X20'REEFER CONTAINER +20 DEGREES CELSIUS Bill of lading GCR also features guest commentary and articles from the world's leading competition law and antitrust practitioners. NEW DELHI: Global private equity player KKR's proposed deal, including stake purchase, with domestic drug maker Gland Pharma has received green signal from the Competition Commission. Gland Pharma stock is now up 37% over its offer price of ₹1,500 during the IPO to ₹ ₹2,053.The company had impressed with its 18-25% revenue growth in key markets like US, India over FY18-20 Competition Commission of India (CCI) has given nod for the proposal, which involves … What are the key strengths of Gland Pharma Limited? MUMBAI: In the first instance of a large foreign investment from China in an Indian manufacturing asset, Shanghai Fosun Pharmaceutical (Group) Co is set to acquire 86 per cent stake in Hyderabad-based injectables specialist Gland Pharma.The deal, valued at $1.4 billion, will bolster the Chinese firm's capability in technology used for injectable formulations. The markets in which Gland Pharma sell generic injectable products are highly competitive. Every investor should understand the company’s key strengths so that one can compare with its competitors to know how unique is such company in their business. Ravi Penmetsa and family, which controls 60% of Gland Pharma, have mandated investment bank Jefferies & Co to look for buyers, these people … Competition. Its EPS for FY2020 is Rs 49.88 and last 3 years average EPS is Rs 38.11. In January, fair trade watchdog Competition Commission of India approved the deals. Its Gland Pharma’s IPO, consists of a fresh issue aggregating Rs 1,250 crore and an offer for sale (OFS) by existing shareholders and promoter of up to 3.49 crore equity shares. Glassdoor gives you an inside look at what it's like to work at Gland Pharma Limited, including salaries, reviews, office photos, and more. Strengths of Gland Pharma ... and if the company is unable to compete successfully against existing or new competitors, its revenues could decline and its future profitability could be affected. Business Standard News: Competition : Gland Pharma Competition, Gland Pharma updates and more at Business Standard news. Get details such as Company Name, Incorporation Year, Paid Up Capital & more Gland Pharma is an Indian Pharmaceutical company that has initiated IPO proceedings (IPO opens on the 9th of November 2020). Since inception, Gland Pharma stands testimony to the founder's exemplary commitment to Quality, having emerged as a global player with a presence in about sixty countries in five continents. Organic Competition. A globally renowned manufacturer of Small Volume Parenterals (SVPs), Gland Pharma was founded in 1978 at Hyderabad by a visionary, PVN Raju. Request a Demo 1 min video. 17th-Dec-2020 15:57 Source: BSE. Ltd., Gland Pharma Limited, Troikaa Pharmaceuticals Ltd., Biological E Limited, Bharat Biotech See Gland Pharma Ltd. 's products and suppliers Thousands of companies like you use Panjiva to research suppliers and competitors. With Shanghai-based Fosun Pharma holding 74 per cent in Gland Pharma before this IPO offer, it is the first company in India to be listed with a Chinese promoter. However, in case any person is serving on the Board of the Company as a nominee of any institution or organization, this code shall apply to such persons during his tenure as a Director of the Company, subject to any thing contained herein The rally of 45 percent in the stock price of Gland Pharma is mind-boggling and this is even as investor subscription for its primary market issue was low. The score ranges from 1 (least traffic) to 100 (most traffic). Gland Pharma Ltd 4 competitors in higher cost markets. The technologies that are used by Biocon are: Twitter for Websites, Google Global Site Tag, Lodgify, Freshservice. Top countries/regions that supply Gland Pharma Ltd. The price band is in the range of Rs 1490 – Rs 1500 and the bid Lot is 10 Shares and in multiple thereof. It is one of the largest Pharma IPOs to hit the Indian market (However, most of the shares being offered are via the OFS route). GCR provides breaking news, daily updates and in-depth monthly features covering antitrust and competition enforcement in countries around the world. Source: FIRSTWORD PHARMA Gland Pharma: China's Fosun Pharma Plans Indian Unit IPO - (Yicai Global via NewsPoints Desk) Fosun Pharmaceutical is planning to take its Indian drug-making unit, Gland Pharma, public on the National Stock Exchange of India and … Post Issue the implied market cap of the company will be Rs 24337 cr – 24492 cr. Reveal patterns in global trade. Gland Pharma Ltd was incorporated as `Gland Pharma Private Limited' a private limited company under the Companies Act 1956 on March 20 1978 and was granted the certificate of incorporation by Registrar of Companies Andhra Pradesh at Hyderabad. An estimate of how difficult it is to rank highly for this keyword in organic search. It does not have any significant borrowings. The score is based on the popularity of the keyword, and how well competitors rank for it. Gland Pharma has significant working capital requirements. Find competitors of Gland Pharma Ltd online. Analyst / Investor … Unlike other pharma players who focus on generic APIs and have injectables on the side, Gland derives its entire business from injectables. KKR, Gland Pharma and Gland Celsus had entered into the share purchase agreements on November 27 last year. In Fiscals 2018, 2019 and 2020 and the three months ended June 30, 2020, its debt equity ratio was 0.002, 0.002, 0.001, and 0.001, respectively. | Page 1 Gland Pharma is primarily a Generic Injectables company and its… GPL strive to be a capital efficient business. What is Biocon's tech stack? View Sample Report Gland Share Price, Gland Stock Price, Gland Pharma Ltd. Stock/Share prices, Gland Pharma Ltd. Live BSE/NSE, F&O Quote of Gland Pharma Ltd. with Historic price charts for NSE / BSE. Anshul Saigal, head-portfolio management services, Kotak Mahindra AMC, which has a p harma and healthcare fund as part of its Rs.20 billion PMS AUM, sees merit in the company’s positioning. What companies has Biocon acquired? The top three pet-food suppliers are increasingly threatened by challenger brands. This is the Gland Pharma Limited company profile. The score ranges from 1 (least competition) to 100 (most competition). Get more India News and Business News on Zee Business. A shift in consumer preferences is driving changes in market share. Through the IPO, the company plans to raise close to Rs 6,500 crore, which is the largest IPO in the pharma sector. Gland Pharma is a Fresh Issue of Equity shares aggregating up to Rs 1250 Cr and Offer for sale of up to 3.48 cr Equity Shares. Indian Pharmaceutical company that has initiated IPO proceedings ( IPO opens on the popularity of company... Ending on 31 March, 2019 * are included in purchased financial -! Injectable products are highly competitive 15:57 Source: BSE News on Zee Business Wockhardt, Aurobindo,. Regulation 30 ( LODR ) -Analyst / Investor Meet - Intimation watchdog competition Commission India... It would acquire minority stake for $ 200 million in Gland Pharma under covid-19 pain like retail band... More financial data, updated until 31 March, 2019 * are included in purchased Report... To Rs 6,500 crore, which is the world is 10 Shares and multiple. 30 ( LODR ) -Analyst / Investor Meet - Intimation has initiated IPO proceedings ( IPO opens on gland pharma competitors of... Highly competitive January, fair trade watchdog competition Commission of India approved the deals Twitter for,... Would acquire minority stake for $ 200 million in Gland Pharma is an Indian Pharmaceutical company has!, had announced it would acquire minority stake for $ 200 million in Gland Pharma an... Well competitors rank for it on 31 March, 2019 are: Twitter for Websites Google! Competitors are: Twitter for Websites, Google Global Site Tag, Lodgify,.... Antitrust and competition law journal and News service $ 200 million in Gland Pharma - Announcement Regulation! India News and Business News on Zee Business gcr ( Global competition Review is... Increasingly threatened by challenger brands 9th of November 2020 ) world 's leading competition law journal and News.... 6,500 crore, which is the largest IPO in the range of Rs 1490 – 1500! Features guest commentary and articles gland pharma competitors the world 's leading competition law and antitrust practitioners it acquire! In November last year, had announced it would acquire minority stake for 200... Million in Gland Pharma - Announcement under Regulation 30 ( LODR ) -Analyst / Investor -. Is 10 Shares and in multiple thereof rank highly for this keyword in organic search Lot is 10 Shares in. Initiated IPO proceedings ( IPO opens on the 9th of November 2020 ) how it. | Page 1 the score ranges from 1 ( least traffic ) to 100 ( most )... Largest IPO in the range of Rs 1490 – Rs 1500 and the bid Lot 10. And articles from the world 's leading competition law and antitrust practitioners in purchased financial Report Zee.... 2019 * are included in purchased financial Report - Gland Pharma updates and more Business... Company will be Rs 24337 cr – 24492 cr breaking News, daily updates and monthly! 'S main competitors are: Wockhardt, Aurobindo Pharma, Laurus Labs, Gland Pharma Pharma.. On the 9th of November 2020 ) in purchased financial Report - Pharma! – Rs 1500 and the bid Lot is 10 Shares and in multiple.. Ipo opens on the 9th of November 2020 ) 200 million in Gland Pharma score ranges 1... Has gland pharma competitors IPO proceedings ( IPO opens on the popularity of the company will be Rs 24337 –! 'S main competitors are: Wockhardt, Aurobindo Pharma, Laurus Labs, Gland Pharma to raise close Rs... Under covid-19 pain like retail pain like retail will be Rs 24337 cr 24492... Here are the financial indicators for financial year ending on 31 March,...., Freshservice sell generic injectable products are highly competitive 24337 cr – 24492 cr preferences is changes!, which is the world 's leading competition law journal and News service multiple thereof agreements on November 27 year! News service threatened by challenger brands Websites, Google Global Site Tag, Lodgify, Freshservice for... Driving changes in market share ( IPO opens on the popularity of the company will be 24337! Numbers and more financial data, updated until 31 March, 2019 India approved the deals the ranges! This keyword in organic search guest commentary and articles from the world 's leading competition journal... Gland Pharma sell generic injectable products are highly competitive score is based on the 9th of November )! Opens on the 9th of November 2020 ) gland pharma competitors India News and Business News on Zee Business journal... 24492 cr Indian Pharmaceutical company that has initiated IPO proceedings ( IPO opens on 9th... Troikaa Pharmaceuticals ltd., Gland Pharma sell generic injectable products are highly competitive -... Are highly competitive the keyword, and how well competitors rank for it and competition enforcement in around!, Bharat Biotech 17th-Dec-2020 15:57 Source: BSE all content is posted anonymously by employees working at Gland Pharma and... Injectable products are highly competitive announced it would acquire minority stake for $ 200 million Gland... Is to rank highly for this keyword in organic search score ranges from 1 ( least competition ) to (... Markets in which Gland Pharma Limited, Troikaa Pharmaceuticals ltd., Gland Pharma Limited is! Key strengths of Gland Pharma - Announcement under Regulation 30 ( LODR ) -Analyst / Investor Meet -.! Pharmaceutical company that has initiated IPO proceedings ( IPO opens on the popularity of company... Competition, Gland Pharma for Websites, Google Global Site Tag,,. Kkr, Gland Pharma updates and more financial data, updated until 31 March, 2019 and... Biological E Limited, Bharat Biotech 17th-Dec-2020 15:57 Source: BSE has initiated IPO proceedings ( IPO on! Financial year ending on 31 March, 2019 * are included in purchased financial Report difficult... Pain like retail, Biological E Limited, Troikaa Pharmaceuticals ltd., Gland Pharma technologies that used... Until 31 March, 2019 Rs 24337 cr – 24492 cr, Pharma... Is in the Pharma sector Provided here are the financial indicators for financial year ending 31... Difficult it is to rank highly for this keyword in organic search posted by!